Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods




delayed childbearing, late reproductive age, infertility, hormonal imbalance, obesity, pregravid preparation


To date, there has been a significant shift in the age structure of pregnant women in developed countries towards an increasing the proportion of older reproductive women (over 35 years). First of all, it is caused by social trends and successes in the development of reproductive medicine, which has both positive and negative consequences.

35+ women are at increased risk of blood pressure and diabetes, first discovered during pregnancy; the risk of having a baby with chromosomal abnormalities increases with age (the most common is Down syndrome); increases the frequency of miscarriages, ectopic pregnancy, placental presentation, stillbirths, births of children with low body weight and asphyxia, delivery by caesarean section.

The article presents up-to-date data on the features of the ovarian reserve, menstrual function and pregnancy onset in late reproductive women. The main risk factors that can prevent the onset of the desired pregnancy in this contingent of women and its normal course, and can cause early reproductive losses are described. The role of nutritional deficits, psychological and physical stressors, infectious component, abortive history, surgical interventions and chronic endometritis that are causes of infertility in women aged 35+ were determined.

Given the identified risk factors the main directions of infertility causes correction and principles of pregravid preparation in women with reproductive disorders, which are recommended to be implemented in conjunction with specialized specialists (family doctor, endocrinologist, cardiologist, and neurologist) are identified. Among the main measures at the pregravid stage is correction of hormonal relations in a woman's body and endometrium state (normalization of the menstrual cycle with provision of its two-phase, correction of luteal phase insufficiency for ovulation), treatment of chronic endometritis, folate supplementation with taking into account hypoproteremia, weight loss, correction of hypertensive disorders, psychological support for married couples

Author Biographies

І. А. Жабченко, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

MD, professor, сhief of the Department of pathology of pregnancy and childbirth

О. Р. Сюдмак, SI “ O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

Junior researcher of the Department of pathology of pregnancy and childbirth


  1. Bulavenko, O.V., Dzis, N.P., Furman, O.V. “Treatment of endometrial hyperplastic processes in women of late reproductive age with overweight.” Reproductive health. Eastern Europe 3.39 (2015): 121–7.
  2. Bulavenko, O.V. “Modern look of the obstetrician-gynecologist at the multivariate complex for children.” Reproductive Endocrinology 3.47 (2019): 64–6.
  3. Gromova, O.A., Torshin, I.Y., Tetruashvili, N.K., Lisitsyna, E.Y. “A systematic analysis of the relationship between vitamin deficiency and congenital malformations.” Consilium Medicum Vol. 6 (2012): 34–40.
  4. Gromova, O.A., Torshin, I.Y., Limanova, O.A. “Prospects for the use of myo-inositol in women with polycystic ovary and insulin resistance in programs of pregravid preparation for in vitro fertilization.” Effective Pharmacotherapy. Obstetrics and gynecology 5.51 (2013).
  5. Dankovich, N.O., Babenko, O.M. “Therapeutic Possibilities of Preparing Women with Infertility for IVF.” Reproductive Endocrinology 2.34 (2017).
  6. Zhabchenko, I.A. “Contemporary view on the role of folates in the prevention of perinatal problems.” Reproductive endocrinology 2.46 (2019): 57–61.
  7. Kalugina, L.V., Yusko, T.I. “Myo-inositol: Therapeutic possibilities and pregravid preparation for polycystic ovary syndrome.” Reproductive endocrinology 4.42 (2018): 40–5.
  8. Silina, N.K., Koval, G.M., Silina, T.N., et al. “Deficiency states in women during pregravid preparation for pregnancy and their correction. Review of International Studies.” A word about health 19 (2019). Obstetrics. Available from: [].
  9. Croce, M.L., Sulage, S.O. “The potential role and therapeutic interest of myo-inositol in metabolic diseases.” Biochimie 95.10 (2013): 1811.
  10. Mashina, M.A. Optimization of specialized care for a barren couple. Thesis for PhD degree. Moscow (2015): 172 p.
  11. Kaminskyi, V.V., Tatarchuk, T.F., et al. “National Consensus on the management of patients with hyperandrogenism.” Reproductive endocrinology 4.30 (2016): 19–31.
  12. Radzinsky, V.E., ed. Ovarian reserve and fertility: difficulties of the 21st century. Information letter. Moscow. Editorial board of the StatusPraesens journal (2015): 24 p.
  13. Podzolkova, N.M., Nazarova, S.V., Chizhova, M.A., Prilepina, I.A. “Pregnancy, luing-ins and perinatal ends for the women of late reproductive age.” Farmateka 3 (2016): 62–7.
  14. Radzinsky, V.E., et al. Pregravid preparation: clinical protocol. Moscow. Editorial board of StatusPraesens journal (2016): 80 p.
  15. Pustotina, O.A., Akhmedova, A.E. “The role of folates in the development of pregnancy complications.” Women's Health 1.117 (2017): 56–61.
  16. Radzinsky, V.E., Ryabinkina, T.S., Raevskaya, O.A. “Technogenic selection.” StatusPraesens 5.42.11 (2017): 103–10.
  17. Bevilakua, A., Carlomanjo, J., Gerley, S., et al. “Results of an international consensus conference on the use of myo-inositol and D-chiro-inositol in obstetrics and gynecology and, in particular, in IVF.” A word about health 19 (2019). Obstetrics. Available from: [].
  18. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva. WHO (2017).
  19. Shestakova, I.G., Ryabinkina, T.S.; ed. by V.E. Radzinsky. PCOS: a new look at the problem. Variety of symptoms, differential diagnosis and treatment of PCOS. Newsletter. Moscow. Editorial board of the StatusPraesens journal (2015): 24 p.
  20. Ryabinkina, T.S., Simonovskaya, H.Y., Rudnev, O.D.; ed. by V.E. Radzinsky. Older reproductive age: contraception and more. Rational contraception of older women: contraceptive and non-contraceptive aspects. Newsletter. Moscow. Editorial board of the StatusPraesens journal (2014): 16 p.
  21. Tatarchuk, T.F., Ganzhyi, I.Y., Pedachenko, N.Y., Kapshuk, I.M. “Current possibilities of non-hormonal treatment of polycystic ovary syndrome in women with obesity.” Reproductive endocrinology 5.13 (2013): 19–21.
  22. Shatkovska, A.S., Shimanska, O.G. “Hormonal contraception in women of late reproductive age.” Medical aspects of women's health 8.37 (2010): 35–40.
  23. Khamoshina, M.B., Lebedeva, M.G., Simonovskaya, H.Y.; ed. by V.E. Radzinsky. Ecological and reproductive dissonance of the XXI century: to prevent negative consequences. Newsletter. Moscow. Editorial board of the StatusPraesens journal (2015): 24 p.
  24. Ismail, A.M., Hamed, A.H., Saso, S., Thabet, H.H. “Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate.” Eur J Obstet Gynecol Reprod Biol 180 (2014): 148–52.
  25. Fauser, B.C.J.M., et al. “Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.” Fertil Steril 97.1 (2012): 28–38.e25.
  26. D’Anna, R., Di Benedetto, V., Rizzo, P., et al. “Myo-inositol may prevent gestational diabetes in PCOS women.” Gynecol Endocrinol 28.6 (2012): 440–2.
  27. Papaleo, E., Unfer, V., Baillargeon, J.P., et al. “Contribution of myo-inositol to reproduction.” Eur J Obstet Gynecol Reprod Biol 147.2 (2009):120–3.
  28. Unfer, V., Carlomagno, G., Dante, G., et al. “Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.” Gynecol Endocrinol 28.7 (2012): 509–15.
  29. Eltbogen, R., et al. “Vitex-agnus-castus-Extrakt (Ze 440) zur Symptom-behandlung bei Frauen mit menstruellen Zyklusstörungen.” Journal fur Gynakologische Endokrinologie 25.2 (2015): 10–5.
  30. Thomson, R.L., Buckley, J.D., Brinkworth, G.D. “Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.” Obes Rev 12 (2011): 202–10.
  31. Genazzani, A.D., Prati, A., Santagni, S., et al. “Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.” Gynecol Endocrinol 28.12 (2012): 969–73.
  32. Unfer, V., Carlomagno, G., Rizzo P., et al. “Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.” Eur Rev Med harmacol Sci 15.4 (2011): 452–7.
  33. Carlomagno, G., De Grazia, S., Unfer, V. “Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use.” Expert Opin Drug Deliv 9.3 (2012): 267–71.
  34. Рapaleo, T., Unfer, V., Baillargeon, J.R., et al. “Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.” Fertil Steril 91 (2009): 1750–4.
  35. Pietrzik, K., еt al. “Folic Acid and L-5-Methyltetrahydrofolate Compression of clinical pharmacokinetics and pharmacodynamics.” Clin Pharmacokinetic 49 (2010): 8.
  36. Jahre, A., Dietl, S., Cupisti, M., et al. “Schwangerschaft und Geburt bei Frauen über 40.” Zollner Geburtshilfe Frauenheilkd 75.08 (2015): 827–32.
  37. Raffone, E., Rizzo, P., Benedetto, V. “Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.” Gynecol Endocrinol 26.8 (2010): 275–80.
  38. Webster, D.E., He, Y., Chen, S.N., et al. “Opioidergic mechanisms underlying the actions of Vitex agnus-castus.” Biochem Pharmacol 81.1 (2011): 170–7.
  39. Artini, P.G., Di Berardino, O.M., Papini F., et al. “Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.” Gynecol Endocrinol 29.4 (2013): 375–9.
  40. Ciotta, L., Stracquadanio, M., Pagano, I., et al. “Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial.” Eur Rev Med Pharmacol Sci 15.5 (2011): 509–14.
  41. Schellenberg, R., Zimmermann, C., Drewe, J., et al. “Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome: multicenter, double-blind, placebo-controlled, randomized, prospective trial.” Phytomedicine 19.14 (2012): 1325–31.



How to Cite

Жабченко, І. А., & Сюдмак, О. Р. (2019). Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods. REPRODUCTIVE ENDOCRINOLOGY, (49), 43–49.